Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Oncology

Journal Scan / Consensus and Guidelines · October 23, 2014

Molecular Testing for Selection of Patients With Lung Cancer

Journal of Clinical Oncology

 

Additional Info

Journal of Clinical Oncology
Molecular Testing for Selection of Patients With Lung Cancer for Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Society for the Study of Lung Cancer/Association of Molecular Pathologists Guideline
J. Clin. Oncol 2014 Nov 10;32(32)3673-9, NB Leighl, N Rekhtman, WA Biermann, J Huang, M Mino-Kenudson, SS Ramalingam, H West, S Whitlock, MR Somerfield

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading